The Smithsonian’s decision to change the name of a work by Félix González-Torres – cancelling out the express tribute to his ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...

This May will see the Tackle HIV Challenging Stigma Garden in full bloom at the RHS Chelsea Flower Show, with visitors set to view how Thomas and Malde have used the magic of horticulture to tell the ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...

Collectively, these status reports reveal a range of significant impacts resulting from the US Government’s decision to freeze and review all US foreign assistance (see the chart below). The situation ...

Senior Economist Xhanti Payi predicts that discussions about the long-term sustainability of HIV/AIDS treatment will take ...

Health scholar explains why that leaves healthcare in Africa on brink of crisis INTERVIEW | U.S. President Donald Trump has ...

Not only does the 35-year-old fear for his own survival as he takes life-saving anti-retroviral (ARV) drugs - but he says he ...

HIV is spread by bodily fluids such as blood, breast milk or semen. It gradually weakens the body's immune system and makes ...